Cardiol Therapeutics Inc (CRDL)
2.15
-0.21
(-8.90%)
USD |
NASDAQ |
May 17, 16:00
2.29
+0.14
(+6.51%)
After-Hours: 18:58
Cardiol Therapeutics Enterprise Value: 134.78M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 134.78M |
| May 15, 2024 | 132.05M |
| May 14, 2024 | 122.49M |
| May 13, 2024 | 122.49M |
| May 10, 2024 | 119.76M |
| May 09, 2024 | 124.54M |
| May 08, 2024 | 110.21M |
| May 07, 2024 | 108.84M |
| May 06, 2024 | 111.57M |
| May 03, 2024 | 109.52M |
| May 02, 2024 | 108.84M |
| May 01, 2024 | 114.30M |
| April 30, 2024 | 110.89M |
| April 29, 2024 | 94.50M |
| April 26, 2024 | 95.87M |
| April 25, 2024 | 99.28M |
| April 24, 2024 | 93.82M |
| April 23, 2024 | 99.28M |
| April 22, 2024 | 93.82M |
| April 19, 2024 | 94.50M |
| April 18, 2024 | 87.68M |
| April 17, 2024 | 93.14M |
| April 16, 2024 | 91.09M |
| April 15, 2024 | 95.87M |
| April 12, 2024 | 100.65M |
| Date | Value |
|---|---|
| April 11, 2024 | 107.47M |
| April 10, 2024 | 101.33M |
| April 09, 2024 | 104.74M |
| April 08, 2024 | 102.01M |
| April 05, 2024 | 103.38M |
| April 04, 2024 | 112.94M |
| April 03, 2024 | 99.28M |
| April 02, 2024 | 97.23M |
| April 01, 2024 | 104.74M |
| March 28, 2024 | 91.96M |
| March 27, 2024 | 91.30M |
| March 26, 2024 | 92.61M |
| March 25, 2024 | 69.08M |
| March 22, 2024 | 70.39M |
| March 21, 2024 | 73.66M |
| March 20, 2024 | 74.96M |
| March 19, 2024 | 73.00M |
| March 18, 2024 | 71.70M |
| March 15, 2024 | 73.00M |
| March 14, 2024 | 66.47M |
| March 13, 2024 | 70.39M |
| March 12, 2024 | 69.08M |
| March 11, 2024 | 64.51M |
| March 08, 2024 | 71.70M |
| March 07, 2024 | 80.19M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-17.01M
Minimum
Nov 09 2022
191.41M
Maximum
Oct 20 2021
53.25M
Average
50.80M
Median
Dec 03 2020
Enterprise Value Benchmarks
| Aurinia Pharmaceuticals Inc | 474.73M |
| Acasti Pharma Inc | 0.8274M |
| Edesa Biotech Inc | 11.74M |
| Lexaria Bioscience Corp | 35.30M |
| Xenon Pharmaceuticals Inc | 2.345B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.610M |
| Total Expenses (Quarterly) | 5.898M |
| EPS Diluted (Quarterly) | -0.0881 |
| Earnings Yield | -15.15% |